Ezetimibe ameliorates atherogenic lipids profiles, insulin resistance and hepatocyte growth factor in obese patients with hypercholesterolemia
出版年份 2015 全文链接
标题
Ezetimibe ameliorates atherogenic lipids profiles, insulin resistance and hepatocyte growth factor in obese patients with hypercholesterolemia
作者
关键词
Anti-obesity agents, Metabolic syndrome, Insulin, Hypolipidemic agents
出版物
Lipids in Health and Disease
Volume 14, Issue 1, Pages 1
出版商
Springer Nature
发表日期
2015-06-18
DOI
10.1186/1476-511x-14-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Effects of Ezetimibe/Simvastatin versus Simvastatin Monotherapy on Platelet and Inflammatory Biomarkers in Patients with Metabolic Syndrome
- (2013) Michael Miller et al. CARDIOLOGY
- A comparison of efficacy and safety of an ezetimibe/simvastatin combination compared with other intensified lipid-lowering treatment strategies in diabetic patients with symptomatic cardiovascular disease
- (2013) Jeffrey B Rosen et al. Diabetes & Vascular Disease Research
- Aldosterone, C-Reactive Protein, and Plasma B-Type Natriuretic Peptide Are Associated With the Development of Metabolic Syndrome and Longitudinal Changes in Metabolic Syndrome Components: Findings from the Jackson Heart Study
- (2013) S. K. Musani et al. DIABETES CARE
- Low serum eicosapentaenoic acid / arachidonic acid ratio in male subjects with visceral obesity
- (2013) Kana Inoue et al. Nutrition & Metabolism
- Prospective Study of Serum Adiponectin and Incident Metabolic Syndrome: The ARIRANG study
- (2012) J.-Y. Kim et al. DIABETES CARE
- Effects of ezetimibe on visceral fat in the metabolic syndrome: a randomised controlled study
- (2012) Hiroyuki Takase et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Double-Blind Randomized Clinical Trial of the Effects of Ezetimibe on Postprandial Hyperlipidaemia and Hyperglycaemia
- (2012) Kaori Kikuchi et al. Journal of Atherosclerosis and Thrombosis
- Ezetimibe Ameliorates Atherosclerotic and Inflammatory Markers, Atherogenic Lipid Profiles, Insulin Sensitivity, and Liver Dysfunction in Japanese Patients with Hypercholesterolemia
- (2012) Noboru Tamaki et al. Journal of Atherosclerosis and Thrombosis
- Lipid-altering efficacy of switching to ezetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk patients with and without metabolic syndrome
- (2011) Maurizio Averna et al. Diabetes & Vascular Disease Research
- Plasma Aldosterone Levels and Development of Insulin Resistance
- (2011) Eita Kumagai et al. HYPERTENSION
- The Effects of Ezetimibe on Surrogate Markers of Cholesterol Absorption and Synthesis in Japanese Patients with Dyslipidemia
- (2011) Shinya Hiramitsu et al. Journal of Atherosclerosis and Thrombosis
- Ezetimibe Ameliorates Metabolic Disorders and Microalbuminuria in Patients with Hypercholesterolemia
- (2011) Shusuke Yagi et al. Journal of Atherosclerosis and Thrombosis
- Remnant-like particle cholesterol and serum amyloid A–low-density lipoprotein levels in obese subjects with metabolic syndrome
- (2011) Kazuhiko Kotani et al. Journal of Clinical Lipidology
- Relationships between lipid profiles and metabolic syndrome, insulin resistance and serum high molecular adiponectin in Japanese community-dwelling adults
- (2011) Ryuichi Kawamoto et al. Lipids in Health and Disease
- Relationships Between Metabolic Syndrome and Other Baseline Factors and the Efficacy of Ezetimibe/Simvastatin and Atorvastatin in Patients With Type 2 Diabetes and Hypercholesterolemia
- (2010) R. B. Goldberg et al. DIABETES CARE
- Effects of Coadministered Ezetimibe Plus Fenofibrate in Mixed Dyslipidemic Patients with Metabolic Syndrome
- (2010) Harold E. Bays et al. Metabolic Syndrome and Related Disorders
- Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Versus Atorvastatin in Patients With Hypercholesterolemia and the Metabolic Syndrome (from the VYMET Study)
- (2009) Jennifer G. Robinson et al. AMERICAN JOURNAL OF CARDIOLOGY
- Ezetimibe added to atorvastatin compared with doubling the atorvastatin dose in patients at high risk for coronary heart disease with diabetes mellitus, metabolic syndrome or neither
- (2009) S. Conard et al. DIABETES OBESITY & METABOLISM
- Fluvastatin/fenofibrate vs. simvastatin/ezetimibe in patients with metabolic syndrome: different effects on LDL-profiles
- (2009) K. Winkler et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- The effect of statin alone or in combination with ezetimibe on postprandial lipoprotein composition in obese metabolic syndrome patients
- (2008) Gideon R. Hajer et al. ATHEROSCLEROSIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More